WO2015107430A3 - Méthodes et biomarqueurs pour la détection et le pronostic du cancer du col de l'utérus - Google Patents

Méthodes et biomarqueurs pour la détection et le pronostic du cancer du col de l'utérus Download PDF

Info

Publication number
WO2015107430A3
WO2015107430A3 PCT/IB2015/000567 IB2015000567W WO2015107430A3 WO 2015107430 A3 WO2015107430 A3 WO 2015107430A3 IB 2015000567 W IB2015000567 W IB 2015000567W WO 2015107430 A3 WO2015107430 A3 WO 2015107430A3
Authority
WO
WIPO (PCT)
Prior art keywords
cervical cancer
biomarkers
detection
methods
prognosis
Prior art date
Application number
PCT/IB2015/000567
Other languages
English (en)
Other versions
WO2015107430A2 (fr
Inventor
Heidi Lyng
Cathinka Halle JULIN
Malin Lando
Original Assignee
Oslo Universitetssykehus Hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oslo Universitetssykehus Hf filed Critical Oslo Universitetssykehus Hf
Publication of WO2015107430A2 publication Critical patent/WO2015107430A2/fr
Publication of WO2015107430A3 publication Critical patent/WO2015107430A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Cette invention concerne des méthodes et des biomarqueurs pour la détection du cancer du col de l'utérus dans des échantillons biologiques, et en particulier des marqueurs d'état de méthylation associés à l'agressivité du cancer du col de l'utérus.
PCT/IB2015/000567 2014-01-16 2015-01-16 Méthodes et biomarqueurs pour la détection et le pronostic du cancer du col de l'utérus WO2015107430A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461928120P 2014-01-16 2014-01-16
US61/928,120 2014-01-16

Publications (2)

Publication Number Publication Date
WO2015107430A2 WO2015107430A2 (fr) 2015-07-23
WO2015107430A3 true WO2015107430A3 (fr) 2015-11-26

Family

ID=53175094

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/000567 WO2015107430A2 (fr) 2014-01-16 2015-01-16 Méthodes et biomarqueurs pour la détection et le pronostic du cancer du col de l'utérus

Country Status (1)

Country Link
WO (1) WO2015107430A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106701801B (zh) * 2017-02-17 2021-07-23 复旦大学 B淋巴瘤和白血病的检测标记物、试剂盒及其应用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108949970A (zh) * 2017-05-23 2018-12-07 中国科学院深圳先进技术研究院 基于多组学的宫颈癌特征获取方法和系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211009A1 (en) * 2005-03-18 2006-09-21 Sungwhan An System for biomarker discovery
WO2013124738A2 (fr) * 2012-02-21 2013-08-29 Oslo Universitetssykehus Hf Méthodes et biomarqueurs permettant de dépister et de pronostiquer le cancer du col utérin

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5639611A (en) 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
CA2036946C (fr) 1990-04-06 2001-10-16 Kenneth V. Deugau Molecules de liaison pour indexation
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5338671A (en) 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
US5714330A (en) 1994-04-04 1998-02-03 Lynx Therapeutics, Inc. DNA sequencing by stepwise ligation and cleavage
ATE226983T1 (de) 1994-08-19 2002-11-15 Pe Corp Ny Gekoppeltes ampflikation- und ligationverfahren
US5695934A (en) 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
US6969488B2 (en) 1998-05-22 2005-11-29 Solexa, Inc. System and apparatus for sequential processing of analytes
US6485944B1 (en) 1997-10-10 2002-11-26 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US6511803B1 (en) 1997-10-10 2003-01-28 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
WO1999019341A1 (fr) 1997-10-10 1999-04-22 President & Fellows Of Harvard College Amplification par replique de reseaux d'acides nucleiques
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
EP1218543A2 (fr) 1999-09-29 2002-07-03 Solexa Ltd. Sequen age de polynucleotides
CN100462433C (zh) 2000-07-07 2009-02-18 维西根生物技术公司 实时序列测定
ATE309393T1 (de) 2001-09-06 2005-11-15 Adnagen Ag Verfahren zum qualitativen und/oder quantitativen nachweis von zellen
US7662594B2 (en) 2002-09-20 2010-02-16 New England Biolabs, Inc. Helicase-dependent amplification of RNA
CA2513889A1 (fr) 2003-01-29 2004-08-19 454 Corporation Sequencage a double extremite
EP2354253A3 (fr) 2003-09-05 2011-11-16 Trustees of Boston University Procede de diagnostic prenatal non effractif
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US7482120B2 (en) 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
EP1844162B1 (fr) 2005-02-01 2014-10-15 Applied Biosystems, LLC Procédé pour détermine un séquence dans un polynucleotide
TR201910868T4 (tr) 2006-02-02 2019-08-21 Univ Leland Stanford Junior Dijital analizle invazif olmayan fetal genetik tarama.
US7282337B1 (en) 2006-04-14 2007-10-16 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
EP2653861B1 (fr) 2006-12-14 2014-08-13 Life Technologies Corporation Procédé pour le séquençage d'un acide nucléique en utilisant des matrices de FET à grande échelle
WO2008157696A2 (fr) 2007-06-19 2008-12-24 Stratos Genomics Inc. Séquençage d'acides nucléiques à haut rendement par expansion
US20100301398A1 (en) 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211009A1 (en) * 2005-03-18 2006-09-21 Sungwhan An System for biomarker discovery
WO2013124738A2 (fr) * 2012-02-21 2013-08-29 Oslo Universitetssykehus Hf Méthodes et biomarqueurs permettant de dépister et de pronostiquer le cancer du col utérin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JOANNA ZHUANG ET AL: "A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform", BMC BIOINFORMATICS, BIOMED CENTRAL, LONDON, GB, vol. 13, no. 1, 24 April 2012 (2012-04-24), pages 59, XP021094786, ISSN: 1471-2105, DOI: 10.1186/1471-2105-13-59 *
MAUREEN A. SARTOR ET AL: "Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis", EPIGENETICS, vol. 6, no. 6, 1 June 2011 (2011-06-01), pages 777 - 787, XP055203591, ISSN: 1559-2294, DOI: 10.4161/epi.6.6.16216 *
SANJA A FARKAS ET AL: "Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer", EPIGENETICS, vol. 8, no. 11, 1 November 2013 (2013-11-01), pages 1213 - 1225, XP055203588, ISSN: 1559-2294, DOI: 10.4161/epi.26346 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106701801B (zh) * 2017-02-17 2021-07-23 复旦大学 B淋巴瘤和白血病的检测标记物、试剂盒及其应用

Also Published As

Publication number Publication date
WO2015107430A2 (fr) 2015-07-23

Similar Documents

Publication Publication Date Title
EP3159398A4 (fr) Kit ou dispositif de détection du cancer du foie, et procédé de détection
EP3504347A4 (fr) Procédés de détection de changements de copie génomique dans des échantillons d'adn
EP3314234A4 (fr) Imageur d'échantillon de biopsie par fluorescence et procédés
EP3119908A4 (fr) Détermination de l'agressivité d'un cancer, de son pronostic et de sa sensibilité à un traitement
EP3194624A4 (fr) Méthodes pour le diagnostic, le pronostic et la surveillance du cancer du sein et réactifs correspondants
EP3207499A4 (fr) Procédés et systèmes pour classifier des échantillons biologiques, comprenant l'optimisation d'analyses et l'utilisation de corrélation
WO2014190286A3 (fr) Méthodes et systèmes d'évaluation non invasive de variations génétiques
EP3159406A4 (fr) Kit ou dispositif de détection du cancer de l' oesophage, et méthode de détection de celui-ci
EP3262454A4 (fr) Imageur d'échantillon de biopsie par fluorescence et procédés
EP3126814A4 (fr) Procédés et systèmes pour le diagnostic et le pronostic du cancer
EP3011055A4 (fr) Système de classification, procédé et trousse pour la classification, la prédiction et le traitement d'un cancer du sein
EP3137902A4 (fr) Nouveaux procédés, tests biologiques, et marqueurs biologiques pour des affections liées au hpv
EP2988131A4 (fr) Marqueur génétique pour la prédiction pronostique et le diagnostic précoces du cancer du sein et leur utilisation
EP3322823A4 (fr) Procédé de diagnostic, de pronostic et de suivi d'un cancer du sein et réactifs correspondants
WO2015153948A3 (fr) Imagerie de microtentacule d'échantillons de tumeur d'un patient
WO2013124738A3 (fr) Méthodes et biomarqueurs permettant de dépister et de pronostiquer le cancer du col utérin
EP4202441A3 (fr) Profil d'expression génétique dans les macrophages pour le diagnostic du cancer
EP3215022A4 (fr) Systèmes et procédés de biopsie
EP3187875A4 (fr) Kit de mesure de substance cible, système de mesure de substance cible, kit de mesure immunochromatographique et système de mesure immunochromatographique
EP3122906A4 (fr) Anticorps anti-hpv16 utilisés en tant que biomarqueurs diagnostiques et pronostiques dans une maladie invasive et pré-invasive
EP3693742A3 (fr) Procédés pour détecter le cancer de la prostate
EP3302479A4 (fr) Biomarqueurs tumoraux et leur utilisation
EP3385717A3 (fr) Procédés de detection du cancer de la prostate
EP3526213A4 (fr) Polyamines urinaires en tant que biomarqueurs de détection du cancer de la prostate
ZA201705679B (en) Photothermal spectroscopy assay readers, and related assay kits and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15721832

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15721832

Country of ref document: EP

Kind code of ref document: A2